Director, Global Market Access Strategy, RWE, HEOR and Pricing

Role: Senior leader responsible for global Market Access, HTA, pricing, and evidence generation strategies for oncology products, focusing on KIMMTRAK (tebentafusp). Responsibilities: develop and lead RWE and HEOR strategies across 40+ countries, collaborate with Commercial, Medical, and Clinical teams to optimize product launch and lifecycle management, oversee pricing and reimbursement negotiations, manage evidence repositories, and shape pipeline strategies through early market access insights. Requirements: 10+ years in global Market Access for oncology within a multinational biopharma, expertise in RWE, HEOR, and patient-reported outcomes, with proven leadership in developing integrated evidence plans, and stakeholder management experience, especially in the US and European markets. Preferred: advanced degree in Health Economics, experience with health policy or epidemiology, and exposure to international cultural considerations. HighValue: Oncology (KIMMTRAK), global HTA and pricing strategies, evidence generation, US and international markets, post-launch lifecycle management, cross-functional collaboration, and stakeholder engagement. WorkSetup: ~20% travel required.